Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00p
  • 52 Week Low: 177.20p
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Friday broker round-up UPDATE

Date: Friday 28 Mar 2014

LONDON (ShareCast) - 888 Holdings: Deutsche Bank lowers target price from 166p to 160p retaining its hold recommendation.

Aberdeen Asset Management: JP Morgan cuts target price from 529p to 509p and stays with its overweight rating.

Advanced Medical Solutions: Investec shifts target price from 121p to 129p, while downgrading from buy to add.

Amlin: Citi shifts target price from 448p to 452p and retains a neutral rating.

Aviva: RBC Capital lowers target price from 500p to 495p and maintains its neutral rating.

Avon Rubber: Investec ups target price from 660p to 680p and upgrades to buy.

Balfour Beatty: Jefferies initiates with a target price of 406p and a buy recommendation.

Beacon Hill Resources: Canaccord Genuity lowers target price from 1.5p to 1.5p and downgrades to a speculative buy recommendation.

British American Tabacco: Goldman Sachs ups target price from 3408p to 3470p maintaining a neutral rating.

Carillion: Jefferies starts with a target price of 518p and a buy recommendation.

Catlin Group: Citi cuts target price from 635p to 605p staying with buy recommendation.

Chesnara: Panmure Gordon ups target price from 322p to 355p and retains a buy recommendation. canaccord Genuity takes target price from 300p to 320p staying with its hold recommendation.

Coca-Cola HBC: Goldman Sachs cuts target price from 1690p to 1618p reiterating its neutral rating.

Costain Group: Jefferies initiates with a target price of 289p and a hold recommendation.

Devro: Societe Generale cuts target price from 250p to 220p and leaves its sell recommendation unchanged.

Diageo: Goldman Sachs cuts target price from 1875p to 1855p leaving its neutral rating unaltered.

Elementis: JP Morgan raises target price from 284p to 320p reiterating an overweight rating.

Galliford Try: Jefferies increases target price from 1303p to 1441p and stays with its hold recommendation.

Hiscox: Citi shifts target price from 673p to 679p and reiterates a neutral rating.

HSBC Holdings: Barclays cuts target price from 780p to 700p maintaining its overweight rating.

Imperial Tabacco: Goldman Sachs reduces target price from 2810p to 2780p leaving its strong buy recommendation unaltered.

Interserve: Jefferies initiates with a target price of 813p and a buy recommendation.

ISG: Jefferies starts with a target price of 381p and a buy recommendation.

ITE Group: Investec reduces target price from 340p to 260p, while leaving its buy recommendation unchanged. Numis cuts target price from 380p to 330p, while keeping its buy recommendation.

Judges Scientific: WH Ireland raises target price from 2150p to 2370p and reiterates a neutral rating.

Kier Group: Jefferies initiates with a target price of 2093p and a buy recommendation.

Kromek Group: Panmure Gordon cuts target price from 92p to 50p and stays with its hold recommendation.

Lancashire Holdings: Citi shifts target price from 850p to 852p and keeps a buy recommendation.

London Stock Exchange: Numis raises target price from 1690p to 1881p, while retaining a hold recommendation.

Micro Focus: Panmure Gordon ups target price from 851p to 878p maintaining its buy recommendation.

Motivcom: Numis reduces target price to 197p, while reiterating its buy recommendation.

Optimal Payments: Canaccord Genuity raises target price from 460p to 575p and keeps a buy recommendation.

Paragon Group: Berenberg takes target price from 395p to 450p and keeps its buy recommendation.

PZ Cussons: Goldman Sachs cuts target price from 450p to 430p retaining a buy recommendation.

Reckitt Benckiser: Nomura increases target price from 5000p to 5200p and maintains a buy recommendation.

Resolution: RBC Capital lowers target price from 400p to 390p, while leaving its outperform rating unchanged.

RPC Group: JP Morgan raises target price from 605p to 675p and keeps its overweight rating.

Royal Mail: RBC Capital ups target price from 625p to 650p upgrading to outperform.

Smith & Nephew: Investec raises target price from 832p to 1100p and upgrades from add to buy.

Sports Direct International: Jefferies initiates with a target price of 1000p and a buy recommendation.

Standard Life: RBC Capital lowers target price from 450p to 440p and reiterates an outperform rating.

Synthomer: JP Morgan takes target price from 244p to 260p and retains a neutral rating.

Tate & Lyle: Societe Generale lowers target price from 750p to 740p, while its buy recommendation remains unchanged.

Unilever: Goldman Sachs cuts target price from 2800p to 2775p staying with its buy recommendation.

Victrex: JP Morgan increases target price from 1550p to 1704p maintaining a neutral rating.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00p
52 Week Low 177.20p
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page